Research Jessica Kean 10/10/23 Research Jessica Kean 10/10/23 FDA's ODAC Votes in Favor of Drug to Reduce Neuroblastoma Relapse Risk Read More Research Jessica Kean 2/27/23 Research Jessica Kean 2/27/23 Introducing CC-DIRECT, a New NCI Public-Private Partnership Read More Research Jessica Kean 11/3/22 Research Jessica Kean 11/3/22 Presenting the 2022 Leonard M. Rosen Memorial Research Award to NCI’s Malcolm Smith Read More Research Jessica Kean 10/21/22 Research Jessica Kean 10/21/22 FDA Approves Sodium Thiosulfate to Prevent Chemo-Induced Hearing Loss in Kids Read More Research Jessica Kean 6/24/22 Research Jessica Kean 6/24/22 New Research Supports Upcoming Meeting on Cardiac Late Effects Read More Research Jessica Kean 4/19/21 Research Jessica Kean 4/19/21 Nausea, Taste, and Schedule Highlighted as Challenges in Survivor Focus Group on Medications Read More Newer Posts Older Posts
Research Jessica Kean 10/10/23 Research Jessica Kean 10/10/23 FDA's ODAC Votes in Favor of Drug to Reduce Neuroblastoma Relapse Risk Read More
Research Jessica Kean 2/27/23 Research Jessica Kean 2/27/23 Introducing CC-DIRECT, a New NCI Public-Private Partnership Read More
Research Jessica Kean 11/3/22 Research Jessica Kean 11/3/22 Presenting the 2022 Leonard M. Rosen Memorial Research Award to NCI’s Malcolm Smith Read More
Research Jessica Kean 10/21/22 Research Jessica Kean 10/21/22 FDA Approves Sodium Thiosulfate to Prevent Chemo-Induced Hearing Loss in Kids Read More
Research Jessica Kean 6/24/22 Research Jessica Kean 6/24/22 New Research Supports Upcoming Meeting on Cardiac Late Effects Read More
Research Jessica Kean 4/19/21 Research Jessica Kean 4/19/21 Nausea, Taste, and Schedule Highlighted as Challenges in Survivor Focus Group on Medications Read More
